相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The impact of HLA donor-specific antibodies on engraftment and the evolving desensitization strategies
Brittany File et al.
BONE MARROW TRANSPLANTATION (2022)
Comparable Outcomes in Acquired Severe Aplastic Anemia Patients With Haploidentical Donor or Matched Related Donor Transplantation: A Retrospective Single-Center Experience
QingYun Wang et al.
FRONTIERS IN MEDICINE (2022)
Successful desensitization of high level donor-specific anti-HLA antibody in patients with hematological diseases receiving haploidentical allografts
Xiaoli Zheng et al.
ANNALS OF HEMATOLOGY (2022)
Donor specific HLA antibody in hematopoietic stem cell transplantation: Implications for donor selection
Scott M. Krummey et al.
FRONTIERS IN IMMUNOLOGY (2022)
Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant
Rebeca Bailen et al.
FRONTIERS IN IMMUNOLOGY (2021)
Emerging New Approaches in Desensitization: Targeted Therapies for HLA Sensitization
Ashley Y. Choi et al.
FRONTIERS IN IMMUNOLOGY (2021)
Treatment of allosensitized patients receiving allogeneic transplantation
Stefan O. Ciurea et al.
BLOOD ADVANCES (2021)
Donor-Specific Antibodies and Primary Graft Failure in Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis
Yiyu Xie et al.
TRANSPLANTATION AND CELLULAR THERAPY (2021)
Caveats of HLA antibody detection by solid-phase assays
Caroline Wehmeier et al.
TRANSPLANT INTERNATIONAL (2020)
Combination treatment of rituximab and donor platelets infusion to reduce donor-specific anti-HLA antibodies for stem cells engraftment in haploidentical transplantation
Rongli Zhang et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2020)
Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibody
Chang Ying-Jun et al.
BONE MARROW TRANSPLANTATION (2020)
Effective desensitization for a strong donor-specific HLA antibody in a case of HLA-mismatched allogeneic hematopoietic cell transplantation
Maneesh K. Misra et al.
HLA (2019)
Class I and II human leukocyte antibodies in pediatric haploidentical allograft candidates: prevalence and risk factors
Meng Lv et al.
BONE MARROW TRANSPLANTATION (2019)
Decitabine-Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft versus Host Disease
Qing Ya Wang et al.
CANCER MANAGEMENT AND RESEARCH (2019)
The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation
Stefan O. Ciurea et al.
BONE MARROW TRANSPLANTATION (2018)
The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology
Lanping Xu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Bortezomib and Immune Globulin Have Limited Effects on Donor-Specific HLA Antibodies in Haploidentical Cord Blood Stem Cell Transplantation: Detrimental Effect of Persistent Haploidentical Donor-Specific HLA Antibodies
Hannah Choe et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Class I and II HLA antibodies in pediatric patients with thalassemia major
Marianne E. McPherson Yee et al.
TRANSFUSION (2016)
Donor Immunization Against Human Leukocyte Class II Antigens is a Risk Factor for Graft-versus-Host Disease
Florent Delbos et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Controlled, Randomized, Open-Label Trial of Risk-Stratified Corticosteroid Prevention of Acute Graft-Versus-Host Disease After Haploidentical Transplantation
Ying-Jun Chang et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Desensitization with plasma exchange in a patient with human leukocyte antigen donor-specific antibodies before T-cell-replete haploidentical transplantation
Stefania Bramanti et al.
TRANSFUSION (2016)
Donor-Specific Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation
Sarah Morin-Zorman et al.
FRONTIERS IN IMMUNOLOGY (2016)
Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation
Stefan O. Ciurea et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets
Ying-Jun Chang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
HLA sensitisation: can it be prevented?
Lesley Rees et al.
PEDIATRIC NEPHROLOGY (2015)
A strategy to reduce donor-specific HLA Abs before allogeneic transplantation
U. Gergis et al.
BONE MARROW TRANSPLANTATION (2014)
Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT
S. Yoshihara et al.
BONE MARROW TRANSPLANTATION (2012)
High Risk of Graft Failure in Patients With Anti-HLA Antibodies Undergoing Haploidentical Stem-Cell Transplantation
Stefan O. Ciurea et al.
TRANSPLANTATION (2009)
分享论文
